HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Overexpression of human carcinoma-associated antigen in esophageal adenocarcinoma and its precursor lesions.

Abstract
The expression of human carcinoma-associated antigen (HCA), a mucin-type glycoprotein, was assessed in 50 esophagogastrectomy specimens. Areas, each from different cases, of Barrett esophagus (n = 36), low-grade dysplasia (n = 38), high-grade dysplasia/carcinoma in situ (n = 26), and esophageal adenocarcinoma (EAC; n = 34) were examined by immunohistochemical stains to 2 anti-HCA monoclonal antibodies, G1 and HAE3. These two antibodies showed similar staining patterns. HCA was overexpressed significantly in EAC and high-grade dysplasia/carcinoma in situ compared with benign esophageal mucosa (P < .001 for both), Barrett esophagus (P < .001 for both), and low-grade dysplasia (P < .025 for both). HCA overexpression did not correlate with the grade of EAC (P > .1). The results suggest that overexpression of HCA might help in diagnosing esophageal dysplasia and cancer. The correlation of HCA with the grade of esophageal dysplasia suggests its possible involvement in the pathogenesis of EAC. HCA also might provide a target for immunotherapy.
AuthorsSonglin Liang, Jorge Yao, Patricia A Bourne, P Anthony diSant'Agnese, Jiaoti Huang, Jun-Yi Lei
JournalAmerican journal of clinical pathology (Am J Clin Pathol) Vol. 122 Issue 5 Pg. 747-51 (Nov 2004) ISSN: 0002-9173 [Print] England
PMID15491971 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Antigens, Tumor-Associated, Carbohydrate
  • Biomarkers, Tumor
Topics
  • Adenocarcinoma
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal
  • Antigens, Tumor-Associated, Carbohydrate (biosynthesis)
  • Barrett Esophagus
  • Biomarkers, Tumor (analysis)
  • Carcinoma in Situ
  • Esophageal Neoplasms (metabolism, pathology)
  • Female
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Precancerous Conditions

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: